Need help finding what you are looking for?
Contact Us
PUBLISHER: DelveInsight | PRODUCT CODE: 2082666
PUBLISHER: DelveInsight | PRODUCT CODE: 2082666
Complex Regional Pain Syndrome (CRPS) - Epidemiology Forecast - 2036
PUBLISHED:
PAGES: 103 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Complex Regional Pain Syndrome (CRPS) Insights and Trends
- According to DelveInsight's analysis, the total prevalent cases of CRPS were found to be 320,000 in the leading markets (the United States, the EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan) in 2025.
- In the 7MM, the total number of gender-specific cases of CRPS was 56,000 for males and 120,000 for females in 2025.
- In 2025, among the 7MM, the US accounted for the highest prevalent cases of CRPS with approximately 230,000 cases. These cases are anticipated to increase during the forecast period.
- The US accounted for the highest number of prevalent cases, followed by the EU4 and the UK, and Japan.
- Diagnosis of CRPS is primarily clinical, as there is no single definitive laboratory or imaging test to confirm the condition. The most widely accepted approach is based on the Budapest criteria.
Complex Regional Pain Syndrome (CRPS) Epidemiology Forecast in the 7MM
- 2025 Incident Cases of CRPS: ~320,000
- CRPS Growth Rate (2026-2036): ~0.5%
DelveInsight's 'Complex Regional Pain Syndrome (CRPS) - Epidemiology Forecast - 2036' report delivers an in-depth understanding of the CRPS, historical and forecasted epidemiology, in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.
Complex Regional Pain Syndrome (CRPS) Understanding and Diagnosis Algorithm
Complex Regional Pain Syndrome (CRPS) Overview and Diagnosis
CRPS, also known as Reflex Sympathetic Dystrophy (RSD), causalgia, and algodystrophy, is a chronic and often progressive pain disorder that typically develops after trauma, surgery, or immobilization. It is broadly classified into CRPS Type I (formerly RSD), where no confirmed nerve injury is present, and CRPS Type II (causalgia), which occurs following a defined nerve injury. The condition is characterized by persistent, severe pain that is disproportionate to the triggering event, along with symptoms such as swelling, skin color and temperature changes, allodynia, and motor dysfunction. Its underlying mechanisms involve neuroinflammation, central and peripheral sensitization, and autonomic dysregulation.
Complex Regional Pain Syndrome (CRPS) Diagnosis
Diagnosis is primarily clinical and is commonly established using the Budapest criteria, which evaluate sensory, vasomotor, sudomotor, and motor/trophic abnormalities. There are no definitive laboratory tests for CRPS. However, imaging techniques such as MRI or bone scintigraphy may support diagnosis and help exclude other conditions. Early diagnosis and intervention are critical to improving outcomes.
Complex Regional Pain Syndrome (CRPS) Epidemiology
Key Findings from CRPS Epidemiological Analysis and Forecast
- Among the types-specific cases of CRPS, Type I accounts for the majority of cases compared to Type II.
- The highest number of age-specific cases was among the age group 40-59 years.
- Among the severity-specific cases of CRPS, moderate to severe accounts for the majority of cases compared to mild.
Scope of the Report:
- The report covers a segment of a descriptive overview of CRPS, explaining its causes, signs and symptoms, and pathogenesis.
- Comprehensive insight has been provided into the epidemiology segments and forecasts, the future growth potential of the diagnosis rate, and disease progression.
Report Insights
Complex Regional Pain Syndrome (CRPS) Patient Population Forecast
Report Key Strengths
- Epidemiology-based (Epi-based) Bottom-up Forecasting
- 11-year Forecast
- Patient Burden Trends (by geography)
FAQs:
- What are the disease risks, burdens, and unmet needs of CRPS? What will be the growth opportunities across the 7MM concerning the patient population with CRPS?
- What is the historical and forecasted CRPS patient pool in the US, EU4 (Germany, France, Italy, and Spain), the UK, and Japan?
Reasons to Buy:
- Insights on patient burden/disease prevalence, evolution in diagnosis, and factors contributing to the change in the epidemiology of the disease during the forecast years.
- To understand key opinion leaders' perspectives on the diagnostic challenges to overcome barriers in the future.
- Detailed insights into various factors hampering disease diagnosis and other existing diagnostic challenges.
Product Code: DIEI1116
Table of Contents
1. Key Insights
2. Report Introduction
3. Executive Summary
4. Epidemiology Methodology of Complex Regional Pain Syndrome (CRPS)
5. Complex Regional Pain Syndrome (CRPS) Epidemiology Overview at a Glance
- 5.1. Patient Share (%) Distribution by Country in 2025 in the 7MM
- 5.2. Patient Share (%) Distribution by Country in 2036 in the 7MM
6. Disease Background And Overview of Complex Regional Pain Syndrome (CRPS)
- 6.1. Introduction
- 6.2. Causes
- 6.3. Signs And Symptoms
- 6.4. Diagnosis
- 6.4.1. Differential Diagnosis
- 6.4.2. Diagnostic Algorithm
7. Epidemiology and Patient Population of Complex Regional Pain Syndrome (CRPS)
- 7.1. Key Findings
- 7.2. Assumption and Rationale
- 7.3. Total Prevalent Cases of Complex Regional Pain Syndrome (CRPS) in the 7MM
- 7.4. The United States
- 7.4.1. Total Prevalent Cases of Complex Regional Pain Syndrome (CRPS) in the United States
- 7.4.2. Total Diagnosed Prevalent Cases of Complex Regional Pain Syndrome (CRPS) in the United States
- 7.4.3. Gender-specific Diagnosed Prevalent Cases of Complex Regional Pain Syndrome (CRPS) in the United States
- 7.4.4. Age-specific Diagnosed Prevalent Cases of Complex Regional Pain Syndrome (CRPS) in the United States
- 7.4.5. Type-specific Diagnosed Prevalent Cases of Complex Regional Pain Syndrome (CRPS) in the United States
- 7.5.6. Severity-specific Diagnosed Prevalent Cases of Complex Regional Pain Syndrome (CRPS) in the United States
- 7.5.6. Total Treated Cases of Complex Regional Pain Syndrome (CRPS) in the United States
- 7.6. EU4 and the UK
- 7.6.1. Total Prevalent Cases of Complex Regional Pain Syndrome (CRPS) in EU4 and the UK
- 7.6.2. Total Diagnosed Prevalent Cases of Complex Regional Pain Syndrome (CRPS) in EU4 and the UK
- 7.6.3. Gender-specific Diagnosed Prevalent Cases of Complex Regional Pain Syndrome (CRPS) in EU4 and the UK
- 7.6.4. Age-specific Diagnosed Prevalent Cases of Complex Regional Pain Syndrome (CRPS) in EU4 and the UK
- 7.6.5. Type-specific Diagnosed Prevalent Cases of Complex Regional Pain Syndrome (CRPS) in EU4 and the UK
- 7.6.6. Severity-specific Diagnosed Prevalent Cases of Complex Regional Pain Syndrome (CRPS) in EU4 and the UK
- 7.6.7. Total Treated Cases of Complex Regional Pain Syndrome (CRPS) in EU4 and the UK
- 7.7. Japan
- 7.7.1. Total Prevalent Cases of Complex Regional Pain Syndrome (CRPS) in Japan
- 7.7.2. Total Diagnosed Prevalent Cases of Complex Regional Pain Syndrome (CRPS) in Japan
- 7.7.3. Gender-specific Diagnosed Prevalent Cases of Complex Regional Pain Syndrome (CRPS) in Japan
- 7.7.4. Age-specific Diagnosed Prevalent Cases of Complex Regional Pain Syndrome (CRPS) in Japan
- 7.7.5. Type-specific Diagnosed Prevalent Cases of Complex Regional Pain Syndrome (CRPS) in Japan
- 7.7.6. Severity-specific Diagnosed Prevalent Cases of Complex Regional Pain Syndrome (CRPS) in Japan
- 7.7.7. Total Treated Cases of Complex Regional Pain Syndrome (CRPS) in Japan
8. Appendix
- 8.1. Bibliography
- 8.2. Report Methodology
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
Product Code: DIEI1116
List of Tables
- Table 1: Summary of Complex Regional Pain Syndrome (CRPS) Epidemiology (2025-2036)
- Table 2:Total Prevalent Cases of Complex Regional Pain Syndrome (CRPS) in the 7MM (2022-2036)
- Table 3: Total Prevalent Cases of Complex Regional Pain Syndrome (CRPS) in the United States (2022-2036)
- Table 4: Total Diagnosed Prevalent Cases of Complex Regional Pain Syndrome (CRPS) in the United States (2022-2036)
- Table 5: Gender-specific Diagnosed Prevalent Cases of Complex Regional Pain Syndrome (CRPS) in the United States (2022-2036)
- Table 6: Age-specific Diagnosed Prevalent Cases of Complex Regional Pain Syndrome (CRPS) in the United States (2022-2036)
- Table 7: Type-specific Diagnosed Prevalent Cases of Complex Regional Pain Syndrome (CRPS) in the United States (2022-2036)
- Table 8: Severity-specific Diagnosed Prevalent Cases of Complex Regional Pain Syndrome (CRPS) in the United States (2022-2036)
- Table 9: Total Treated Cases of Complex Regional Pain Syndrome (CRPS) in the United States (2022-2036)
- Table 10: Total Prevalent Cases of Complex Regional Pain Syndrome (CRPS) in EU4 and the UK (2022-2036)
- Table 11: Total Diagnosed Prevalent Cases of Complex Regional Pain Syndrome (CRPS) in EU4 and the UK (2022-2036)
- Table 12: Gender-specific Diagnosed Prevalent Cases of Complex Regional Pain Syndrome (CRPS) in EU4 and the UK (2022-2036)
- Table 13: Age-specific Diagnosed Prevalent Cases of Complex Regional Pain Syndrome (CRPS) in EU4 and the UK (2022-2036)
- Table 14: Type-specific Diagnosed Prevalent Cases of Complex Regional Pain Syndrome (CRPS) in EU4 and the UK (2022-2036)
- Table 15: Severity-specific Diagnosed Prevalent Cases of Complex Regional Pain Syndrome (CRPS) in EU4 and the UK (2022-2036)
- Table 16: Total Treated Cases of Complex Regional Pain Syndrome (CRPS) in EU4 and the UK (2022-2036)
- Table 17: Total Prevalent Cases of Complex Regional Pain Syndrome (CRPS) in Japan (2022-2036)
- Table 18: Total Diagnosed Prevalent Cases of Complex Regional Pain Syndrome (CRPS) in Japan (2022-2036)
- Table 19: Gender-specific Diagnosed Prevalent Cases of Complex Regional Pain Syndrome (CRPS) in Japan (2022-2036)
- Table 20: Age-specific Diagnosed Prevalent Cases of Complex Regional Pain Syndrome (CRPS) in Japan (2022-2036)
- Table 21: Type-specific Diagnosed Prevalent Cases of Complex Regional Pain Syndrome (CRPS) in Japan (2022-2036)
- Table 22: Severity-specific Diagnosed Prevalent Cases of Complex Regional Pain Syndrome (CRPS) in Japan (2022-2036)
- Table 23: Total Treated Cases of Complex Regional Pain Syndrome (CRPS) in Japan (2022-2036)
List of Figures
- Figure 1: Signs and symptoms of Complex Regional Pain Syndrome (CRPS)
- Figure 2:Total Prevalent Cases of Complex Regional Pain Syndrome (CRPS) in the 7MM (2022-2036)
- Figure 3: Total Prevalent Cases of Complex Regional Pain Syndrome (CRPS) in the United States (2022-2036)
- Figure 4: Total Diagnosed Prevalent Cases of Complex Regional Pain Syndrome (CRPS) in the United States (2022-2036)
- Figure 5: Gender-specific Diagnosed Prevalent Cases of Complex Regional Pain Syndrome (CRPS) in the United States (2022-2036)
- Figure 6: Age-specific Diagnosed Prevalent Cases of Complex Regional Pain Syndrome (CRPS) in the United States (2022-2036)
- Figure 7: Type-specific Diagnosed Prevalent Cases of Complex Regional Pain Syndrome (CRPS) in the United States (2022-2036)
- Figure 8: Severity-specific Diagnosed Prevalent Cases of Complex Regional Pain Syndrome (CRPS) in the United States (2022-2036)
- Figure 9: Total Treated Cases of Complex Regional Pain Syndrome (CRPS) in the United States (2022-2036)
- Figure 10: Total Prevalent Cases of Complex Regional Pain Syndrome (CRPS) in EU4 and the UK (2022-2036)
- Figure 11: Total Diagnosed Prevalent Cases of Complex Regional Pain Syndrome (CRPS) in EU4 and the UK (2022-2036)
- Figure 12: Gender-specific Diagnosed Prevalent Cases of Complex Regional Pain Syndrome (CRPS) in EU4 and the UK (2022-2036)
- Figure 13: Age-specific Diagnosed Prevalent Cases of Complex Regional Pain Syndrome (CRPS) in EU4 and the UK (2022-2036)
- Figure 14: Type-specific Diagnosed Prevalent Cases of Complex Regional Pain Syndrome (CRPS) in EU4 and the UK (2022-2036)
- Figure 15: Severity-specific Diagnosed Prevalent Cases of Complex Regional Pain Syndrome (CRPS) in EU4 and the UK (2022-2036)
- Figure 16: Total Treated Cases of Complex Regional Pain Syndrome (CRPS) in EU4 and the UK (2022-2036)
- Figure 17: Total Prevalent Cases of Complex Regional Pain Syndrome (CRPS) in Japan (2022-2036)
- Figure 18: Total Diagnosed Prevalent Cases of Complex Regional Pain Syndrome (CRPS) in Japan (2022-2036)
- Figure 19: Gender-specific Diagnosed Prevalent Cases of Complex Regional Pain Syndrome (CRPS) in Japan (2022-2036)
- Figure 20: Age-specific Diagnosed Prevalent Cases of Complex Regional Pain Syndrome (CRPS) in Japan (2022-2036)
- Figure 21: Type-specific Diagnosed Prevalent Cases of Complex Regional Pain Syndrome (CRPS) in Japan (2022-2036)
- Figure 22: Severity-specific Diagnosed Prevalent Cases of Complex Regional Pain Syndrome (CRPS) in Japan (2022-2036)
- Figure 23: Total Treated Cases of Complex Regional Pain Syndrome (CRPS) in Japan (2022-2036)
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.